Showing results (1-10 of 277) with videos related to
Sort By:
Pageof 28
Advances in Therapy|March 12, 2011
Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosisE Ann Yeh, B Weinstock-GuttmanDrugs|April 25, 2000
What is new in the treatment of multiple sclerosis?B Weinstock-Guttman, L D JacobsCNS Drugs|January 23, 2013
Prescribing recommendations for interferon-Beta in multiple sclerosisB Weinstock-Guttman, R A RudickDrug Safety|February 1, 1996
Newer versus older treatments for relapsing-remitting multiple sclerosisB Weinstock-Guttman, J A CohenJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Neurologic complications of immunosuppressive and anti-inflammatory therapy for rheumatic diseasesB Weinstock-Guttman, D Nair, J A CohenJournal of Computer Assisted Tomography|July 1, 1995
Unusual long-standing Gd-DTPA enhancement in a chronic progressive myelopathyB Weinstock-Guttman, J S Ross, R M RansohoffMultiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
An association between autoreactive antibodies and anti-interferon-beta antibodies in multiple sclerosisN Garg, B Weinstock-Guttman, K Bhasi, et al.The Journal of Clinical Investigation|April 1, 1997
Diversity and plasticity of self recognition during the development of multiple sclerosisV K Tuohy, M Yu, B Weinstock-Guttman, et al.European Journal of Neurology|January 10, 2018
Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal studyR Zivadinov, J Hagemeier, N Bergsland, et al.Current Treatment Options in Neurology|August 13, 2011
Current therapeutic options in pediatric multiple sclerosisE Ann YehPageof 28